Shore. Role of tachykinins in airway responses to ozone in rats. J. Appl. Physiol. 85(2): 442-450, 1998.-Previous studies that used neonatal capsaicin (Cap) treatment to ablate C fibers indicate that C fibers act to inhibit lung damage and airway hyperresponsiveness after ozone (O 3 ) exposure in rats. The purpose of this study was to determine 1) the role of tachykinins in these protective effects and 2) whether differences in minute ventilation (V E) during O 3 exposure might account for the effect of Cap. In the first study, male SpragueDawley rats were exposed to 1 part/million O 3 or air for 3 h. Four hours later, a bronchoalveolar lavage (BAL) was performed or airway responsiveness was measured. Rats were treated with CP-99994 and SR-48968, selective neurokinin-1-and -2-receptor antagonists, respectively, or with vehicle (Veh). O 3 caused an increase in the number of neutrophils recovered from BAL fluid in both the Veh-treated and tachykinin-receptor antagonist (TKRA)-treated rats, but the number of neutrophils was approximately twofold greater in the TKRA-treated rats. In contrast, TKRA treatment had no effect on baseline pulmonary mechanics or airway responsiveness. After O 3 exposure, the number of neutrophils in BAL fluid was also greater in Cap-than in Veh-treated rats. O 3 reduced V E in both Veh-and Cap-treated rats, but the response was greater (reduction of 44.7 Ϯ 3.7 vs. 27.8 Ϯ 6.8%) and occurred earlier (10 vs. 70 min) in Cap-than in Vehtreated rats (P Ͻ 0.02). These results suggest that tachykinins mediate protective effects of C fibers against O 3 -induced lung inflammation. The results also indicate that the more pronounced effect of O 3 on BAL neutrophils in Cap-treated rats is not the result of a greater inhaled dose of O 3 resulting from greater V E. airway responsiveness; bronchoconstriction; methacholine; C fibers; ventilation; CP-99994; SR-48968; bronchoalveolar lavage; tidal volume; breathing frequency C FIBERS, a class of unmyelinated sensory neurons, innervate the lungs and airways of many species, including humans. The terminal ramifications of these neurons are found underneath and between epithelial cells, around blood vessels, and near airway smooth muscle and mucous glands (2, 24). In response to stimulation, the tachykinins, substance P (SP) and neurokinin A (NKA), are released from the peripheral endings of these neurons. The biological effects of these peptides in the lung and airways are diverse. Tachykinins can induce bronchoconstriction, increase microcirculation, cause mucous secretion, and increase vascular permeability (19) . Stimulation of C fibers also causes apnea, followed by rapid, shallow breathing (33). C fibers are stimulated by various inhaled irritants including ozone (O 3 ) (4) as well as by many endogenous inflammatory mediators (19). In addition, SP is released into the airway lavage fluid of humans exposed to O 3 (12).
C FIBERS, a class of unmyelinated sensory neurons, innervate the lungs and airways of many species, including humans. The terminal ramifications of these neurons are found underneath and between epithelial cells, around blood vessels, and near airway smooth muscle and mucous glands (2, 24) . In response to stimulation, the tachykinins, substance P (SP) and neurokinin A (NKA), are released from the peripheral endings of these neurons. The biological effects of these peptides in the lung and airways are diverse. Tachykinins can induce bronchoconstriction, increase microcirculation, cause mucous secretion, and increase vascular permeability (19) . Stimulation of C fibers also causes apnea, followed by rapid, shallow breathing (33) . C fibers are stimulated by various inhaled irritants including ozone (O 3 ) (4) as well as by many endogenous inflammatory mediators (19) . In addition, SP is released into the airway lavage fluid of humans exposed to O 3 (12) .
Neonatal capsaicin (Cap) pretreatment causes degeneration of C fibers and decreases neuropeptide content in the lungs and airways (14, 27) . Our laboratory (15) has previously reported that, in Sprague-Dawley rats treated neonatally with Cap, airway hyperresponsiveness to inhaled methacholine is induced by exposure to concentrations of O 3 , which do not affect responsiveness in control rats. Neonatal Cap treatment also results in more airway epithelial injury and more inflammation after O 3 exposure, as determined by pathology and bronchoalveolar lavage (BAL) in Wistar rats (37) . Taken together, these results suggest that C fibers protect the airways during exposure to O 3 , minimizing airway injury and inflammation and inhibiting the development of airway hyperresponsiveness. C fibers have also been shown to play a protective role in the responses to other inhaled irritants such as sulfur dioxide (22, 23) , hydrogen sulfide (30) , and acrolein (41) .
One aim of this study was to determine whether tachykinins were important in mediating these protective effects of C fibers against O 3 -induced airway inflammation and airway hyperresponsiveness in rats. To this end, we treated rats with tachykinin-receptor antagonists (TKRAs) or the vehicle (Veh) used to dissolve them, exposed them to O 3 or air, and then either performed a BAL or instrumented them for the measurement of pulmonary mechanics and responsiveness to inhaled aerosolized methacholine. The TKRAs, CP-99994 and SR-48968, which possess high potency and selectivity in blocking the neurokinin-1 (NK 1 ) and -2 (NK 2 ) receptors, respectively (8, 26) , were employed. Because our experiments were performed in SpragueDawley rats, whereas those of Sterner-Kock et al. (37) were performed in Wistar rats, and because differences in responses to tachykinins and to O 3 have been observed among strains of rat (9, 16, 39, 42) , we also examined the effect of neonatal Cap treatment on O 3 -induced alterations in BAL cells and protein and confirmed the results of Sterner-Kock et al. (37) indicating that ablation of C fibers causes more lung injury and inflammation after O 3 inhalation.
One explanation for the greater inflammatory response of the Cap-treated rats is that a larger dose of O 3 is delivered to the lungs of these rats despite a similar O 3 concentration. The dose of O 3 delivered to the lungs is a function of both O 3 concentration and minute ventilation (V E) (47) . During O 3 exposure, rats decrease their V E (1, 25) . Because O 3 stimulates C fibers and stimulation of C fibers alters V E (4, 33) , it is possible that C fibers are the sensory arm of O 3 -induced changes in V E. If so, one might expect V E to be reduced during O 3 exposure in normal rats, but not in Cap-treated rats lacking C fibers, leading to an overall greater dose of O 3 in the Cap-treated rats. To test this hypothesis, we measured V E and its components, tidal volume (VT) and breathing frequency (f), during exposure of awake Veh-and Cap-treated rats to O 3 or air.
METHODS
Animals. This study protocol was approved by the Harvard Medical Area Standing Committee on Animals. For the studies with TKRAs, pathogen-free Sprague-Dawley rats were obtained from Charles River Breeding Laboratories (Wilmington, MA) and were housed in group cages. For the study with neonatal Cap treatment, pregnant female SpragueDawley rats were purchased from Charles River and were housed individually. In each litter, rats were treated either with 50 mg/kg of Cap, dissolved in a mixture of 10% Tween 80 and 10% ethanol in saline, or with an equivalent amount of Veh subcutaneously 2 or 3 days after their birth. During Cap treatment, rats were anesthetized with halothane. The rats were weaned at 1 mo of age, and males and females were separated.
Verification of Cap desensitization. Our laboratory has previously reported that neonatal Cap pretreatment performed in this manner decreases tachykinins in lung and other tissues (15, 23) . To confirm a decrease in tachykinins in these rats, six Veh-and six Cap-pretreated rats from the same cohort used for measurements of ventilatory responses to O 3 were killed with an overdose of pentobarbital sodium, and the lungs were excised. The lungs were immediately frozen in liquid nitrogen and stored at Ϫ70°C until extraction and assay for SP content by an enzyme-linked immunosorbent assay. SP was extracted from the lungs as previously described (18) . The enzyme-linked immunosorbent assay for SP was performed by using methods described by Folkesson et al. (10) . The antibody for SP was purchased from Peninsula Laboratories (Belmont, CA). The lower limit of detection of this assay was 3 fmol of SP, and the assay has Ͻ0.01% cross-reactivity with NKA (18) . Cap pretreatment significantly reduced the SP content of the lungs from 2.83 Ϯ 0.5 to 1.75 Ϯ 0.1 pmol/g tissue (P Ͻ 0.002).
O 3 exposure. Exposure to O 3 or filtered room air was conducted in a stainless steel chamber with a Plexiglas door on the front (ϳ145 liters in volume). O 3 was generated by passing dry 100% O 2 through ultraviolet light and mixing it with filtered room air in the chamber. Chamber atmosphere was drawn continuously via a sampling port, and O 3 concentration was measured by an O 3 chemiluminescent analyzer (model 49, Thermoelectron Instruments, Hopkinton, MA), which was calibrated by an ultraviolet photometric O 3 calibrator (model 49PS, Thermoelectron Instruments).
Experimental protocol. Two different studies were performed. The purpose of the first study (TKRA) was to determine whether tachykinins act to limit airway injury and inflammation induced by O 3 and thereby limit the degree of airway hyperresponsiveness induced by O 3 . In this study, rats were treated with CP-99994 (0.75 mg/kg ip) and SR-48968 (0.75 mg/kg ip) or with Veh 15 min before exposure to filtered air or O 3 . The rats were then exposed to air or O 3 [1 part/million (ppm), for 3 h] and were retreated with the same doses of CP-99994 and SR-48968 or the Veh immediately after the exposure to ensure continued receptor blockade. These doses of TKRAs were chosen based on reports that indicated their effectiveness in inhibiting responses to SP and NKA in rats and guinea pigs (8, 13, 26, 36) . Four hours after the air or O 3 exposure had ended, rats were killed, and BAL was performed. Alternatively, 2 h after exposure, rats were anesthetized for the measurement of airway responsiveness to inhaled methacholine, followed by administration of intravenous SP to confirm the efficacy of the antagonists. The time required to anesthetize the animals, perform the necessary surgery, instrument them, and perform the measurements of responsiveness was such that the measurements of the steep part of the dose-response curve coincided in time with BAL performed in the other animals.
The purpose of the second study was to confirm, in SpragueDawley rats, reports about Wistar rats indicating that Captreated rats that lack C fibers have increased airway injury and airway inflammation after O 3 exposure (37) . We also sought to determine whether differences in V E during O 3 exposure might contribute to these enhanced responses. Two cohorts of rats were used in this study (Cap) . In the first cohort, adult rats with or without neonatal Cap treatment were exposed either to 1 ppm O 3 or to filtered air for 3 h. To evaluate inflammatory changes induced by O 3 , BAL was performed 4 h after the end of O 3 exposure. In the second cohort, adult rats treated neonatally with either Cap or Veh were placed in head-out restraining tubes that served as body plethysmographs. Once the animal was in the tube, the cranial end of the tube was inserted into a port in the door of the O 3 -exposure chamber, so that animals breathed air from within the chamber. We then monitored V E for 45 min before O 3 was introduced into the chamber. O 3 exposures (2 ppm) were for 90 min followed by a 45-to 90-min recovery period during which we continued to monitor V E. For these experiments, the washin of O 3 was such that 2 ppm was reached within 5 min of initiating the exposure. The washout was such that O 3 had decreased to Ͻ0.02 ppm within 5 min after the O 3 flow to the chamber was stopped. Other Cap-and Veh-treated rats were treated identically but were exposed to filtered air only.
Measurements of pulmonary mechanics and airway responsiveness to inhaled aerosolized methacholine were performed as previously described (15) . Briefly, rats were anesthetized with pentobarbital sodium (64.8 mg/kg ip), tracheostomized with a tubing adapter (14 gauge, 1.65-mm ID), and mechanically ventilated with a rodent ventilator (Harvard Apparatus, Natick, MA) at 8 ml/kg and 60 breaths/min. End-expiratory pressure was maintained at 3.5 cmH 2 O throughout the experiment. The left carotid and right jugular vein were catheterized for blood pressure measurement and drug administration, respectively. The chest wall was opened widely to expose the lungs to atmospheric pressure, and the rat was then placed in a body plethysmograph. Plethysmograph pressure relative to a reference bottle of a similar size was measured with a differential pressure transducer (model LCVR, Celesco, Canoga Park, CA) and used as a volume signal. Flow was calculated by electrical differentiation of the volume signal. Transpulmonary pressure was obtained with a second pressure transducer (Celesco) placed between a side tap in a tracheal cannula and the inside of the plethysmograph. All three signals were recorded on a strip chart (model RS65P, General Scanning, Watertown, MA) and fed to a computer for calculation of dynamic compliance (Cdyn) and pulmonary conductance (GL), according to the method of Von Neergard and Wirz (44, 45) .
Airway responsiveness was measured as follows. A breath equal to three times VT was given to provide a constant volume history. Baseline measurements of GL and Cdyn were obtained 1 min later. Animals were then given 20 tidal breaths of aerosolized saline generated in an acorn nebulizer. A flow rate of 4.5 l/min was used to generate the aerosol. GL and Cdyn were then measured repeatedly over the next 3 min, and the peak response was recorded. The procedure was then repeated by using methacholine solutions in the nebulizer, beginning with 0.1 mg/ml and increasing in one-half log units up to 300 mg/ml. The time interval between doses was sufficient for GL to return to within 10% of its original value or the time interval was 10 min, whichever came first. GL and Cdyn values measured before the methacholine challenge are reported as baseline values. The methacholine doses required to produce a 50% decrease of GL and Cdyn were determined by log-linear interpolation between the two doses bounding the point at which GL or Cdyn was exactly 50% of its baseline value.
At the end of the methacholine challenge, changes in blood pressure caused by intravenous infusions of increasing concentrations of SP were measured to confirm the efficacy of the TKRAs. The doses of SP ranged from 10 Ϫ12 to 10 Ϫ10 mol/kg. SP was injected over 20 s, and each administration was separated by 5 min. This time interval was sufficient for blood pressure to return to the baseline level.
BAL. Animals were given a lethal dose of pentobarbital sodium (64.8 mg in 1.0 ml) intravenously. The chest wall was opened, and the lungs were then lavaged twice with 5 ml of saline. For the lavages, saline was injected and withdrawn gently over 30 s. The recovered BAL fluid was centrifuged at 1,200 rpm at 4°C for 10 min. Cell pellets were resuspended in 5 ml of saline, and the total number of cells was counted by a hemocytometer. Aliquots of cells were also centrifuged onto glass slides at 800 rpm for 5 min (Cytospin2, Shandon, Sewickley, PA), air-dried, and stained with Wright-Giemsa (LeukoStat, Fisher Scientific, Pittsburgh, PA). Cell differentiation was determined by the counting of 1,200 cells under ϫ400 magnification. Total protein concentration in the BAL supernatant was determined by the Bradford technique.
Monitoring of V E. Rats were placed in a Plexiglas restraining tube, which served as a head-out flow plethysmograph. The tube was fitted with a silicone rubber gasket designed to fit snugly around the animal's neck and seal the head from the rest of the body. Once the animal was in the tube, a large piston was moved into placed behind the animal. The piston served to prevent the animal from moving and to seal the body chamber from the outside air. Air, displaced at the body surface as the animal breathed, passed across a pneumotachograph (8-mm diameter fitted with a screen filter), designed and fabricated in-house and attached to a differential pressure transducer (model 163PC01D75, Omega Engineering). The resulting flow signal was analyzed by a computer program (BUXCO, Troy, NY) that computed V E, VT, f, and inspiratory (TI) and expiratory time (TE) on a breath-bybreath basis and reported the average of each of these values every minute.
Chemicals. Methacholine chloride and SP were purchased from Sigma Chemical (St. Louis, MO) and were dissolved in saline. CP-99994 and SR-48968 were synthesized at Merck Frosst and were dissolved in a 1:1 solution of saline and polyethylene glycol (average mol wt 200; Sigma Chemical). Cap was obtained from Spectrum Chemical Manufacturing.
Statistical analysis. Results are expressed as means Ϯ SE. For baseline values of pulmonary mechanics and log 50% effective dose data, analysis of variance was employed to detect differences across all groups in the TKRA study. The effect of TKRAs on changes in blood pressure induced by SP was examined by using Student's t-test. For BAL data, analysis of variance was first employed to detect differences across all groups. If a statistically significant result was observed, follow-up t-tests were used to determine the significance of differences across groups. The Bonferroni correction was employed to correct for multiple comparisons. Because there were no significant differences in any BAL parameter between the two air-exposed groups, the air-exposed animals were combined for these comparisons. For ventilatory parameters, mean values over the 20 min immediately preceding O 3 exposure were determined for each animal, and data are reported as percent changes from those values. In each animal, 5-min averages around the 10-, 30-, 50-, 70-, and 90-min time points for O 3 exposure were computed. The effect of Cap treatment on these parameters was then assessed by repeated-measures analysis of variance. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
TKRA study. To determine whether tachykinins released from C fibers act to limit O 3 -induced airway injury and inflammation, we examined the effect of TKRAs on BAL cells and protein in O 3 -exposed animals. The profile of cells recovered from BAL was affected by both O 3 exposure and TKRA treatment ( Table 1) . Analysis of variance indicated significant differences across the groups in the number of BAL neutrophils and ciliated epithelial cells and the BAL protein concentration, whereas total cell numbers, lymphocytes, and macrophages were unchanged. Treatment with TKRAs did not affect either the BAL cell profile or the BAL protein concentration in air-exposed rats. O 3 exposure increased the number of neutrophils in both the Veh-and the TKRA-treated rats, compared with air-exposed controls. However, the number of neutrophils recovered from the TKRA-treated rats exposed to O 3 was significantly greater than that from the Veh-treated rats exposed to O 3 . O 3 exposure also increased BAL epithelial cells and BAL protein concentration in both the Veh-and the TKRA-treated rats, compared with air-exposed controls (Table 1) . However, in contrast to the effect of TKRA on BAL neutrophils, there was no difference in BAL epithelial cells or BAL protein concentration between the TKRA-treated rats exposed to O 3 and the Veh-treated rats exposed to O 3 .
We also measured pulmonary mechanics and airway responsiveness to inhaled aerosolized methacholine in TKRA-and Veh-treated rats exposed to air or O 3 . Exposure to O 3 did not alter baseline airway mechanics or induce airway hyperresponsiveness to inhaled methacholine in either the Veh-or TKRA-treated rats (Table 2) .
To confirm the efficacy of the TKRA treatment, after the measurements of airway responsiveness to methacholine were taken, changes in blood pressure induced by SP were assessed (Table 3) . Infusion of SP caused a triphasic blood pressure change as reported by others (35) : an immediate fall phase, recovery within 1 min, and, at higher doses, an extended secondary decrease. The lowest mean blood pressure observed in the first phase is reported. Intravenous injection of 10 Ϫ12 mol/kg of SP did not alter blood pressure in either the Veh-or the TKRA-treated groups. In the Veh-treated animals, 10 Ϫ11 mol/kg SP caused a significant decrease in blood pressure. In the TKRA-treated groups, the same dose of SP had no effect (P Ͻ 0.05 compared with the Veh group). At 10 Ϫ10 mol/kg, blood pressure fell in both groups, but the decrease was greater in the Veh-treated than in the TKRA-treated group.
Cap study. To verify a protective role for C fibers in the airway inflammation and injury induced by O 3 exposure in Sprague-Dawley rats, as had previously been demonstrated in Wistar rats (37) , adult rats treated neonatally with Cap or the Veh used to dissolve Cap were exposed to air or O 3 , and a BAL was performed. The results are summarized in Table 4 . Analysis of variance indicated a statistically significant difference across groups in the numbers of neutrophils, lymphocytes, and ciliated epithelial cells and in total protein. Follow-up analysis indicated that, compared with air-exposed controls, the numbers of neutrophils and ciliated epithelial cells were increased significantly in both the O 3 -exposed, Cap-treated group and the O 3 -exposed, Veh-treated group. As was observed with TKRA treatment, the number of neutrophils in BAL fluid recovered from Cap-treated animals exposed to O 3 was significantly greater than was the number of neutrophils recovered from BAL of Veh-treated animals exposed to O 3 . Compared with air-exposed animals, the total protein concentration was elevated in the O 3 -exposed, Cap-treated group but not in the Veh-treated group.
To determine whether the effective dose of O 3 delivered to the lungs might be different in Cap-and Veh-treated rats, we measured V E and examined the pattern of breathing during air or O 3 exposure. Table 5 shows mean baseline ventilatory parameters measured during the 20 min immediately before O 3 (or air) exposure (after the animals were allowed 25 min to settle in the restraining tubes). No significant differences between Cap-and Veh-treated rats were observed.
In Cap-and Veh-treated rats exposed to filtered air, there was substantial minute-to-minute variability in V E, but no significant trend over time in either group and no significant effect of Cap treatment (Fig. 1) . Similarly, no significant changes in VT, f, TI, or TE were observed with time in air-exposed animals (data not shown). Figure 2 shows the effect of a 90-min O 3 exposure on ventilatory parameters in O 3 -exposed rats. O 3 caused a decrease in V E in both Veh-and Cap-treated rats, but there was a significant effect of Cap treatment on this response (P Ͻ 0.018). In Cap-treated rats, a significant decrease in V E occurred within 10 min of O 3 exposure, whereas a significant decrease in V E was not observed in the Veh-treated animals until after 70 min of O 3 exposure.
In both groups, the change in V E was primarily the result of a decrease in VT (Fig. 2) , and, again, there was a significant effect of Cap treatment on O 3 -induced changes in VT. (P Ͻ 0.012). VT decreased earlier in the Cap-treated rats (30 min) than in the Veh-treated controls (70 min). There was substantial variability in the f response to O 3 exposure among rats. Some rats showed an increase in f, whereas others showed a decrease. For Veh-treated rats, the mean effect was no net change over time, whereas for the Cap-treated rats, there was a statistically significant decrease in f 10 min Values are means Ϯ SE; n ϭ 4 animals for air-exposed and 6 for O 3 -exposed groups. GL, pulmonary conductance; Cdyn, dynamic compliance; ED 50 GL and ED 50 Cdyn , inhaled methacholine dose required to decrease GL and Cdyn, respectively, by 50% of their baseline values. No statistically significant difference was detected. after O 3 exposure but not at any other time point (Fig.  2) . Overall, there was no significant effect of Cap treatment on f. Even though f was not altered by O 3 exposure, the timing of the breath was altered. In particular, TI increased in the first 10 min of O 3 exposure and then decreased to values well below baseline over the next 60 min (Fig. 2) . In contrast, TE increased over the course of O 3 exposure (Fig. 2) , although the changes were much more variable among animals. There were no statistically significant differences between Cap-and Veh-treated animals in the changes in TI and TE induced by O 3 exposure.
DISCUSSION
The results of the present study demonstrate that combined inhibition of NK 1 and NK 2 tachykinin receptors during exposure to O 3 augments neutrophil influx into the lungs and airways (Table 1 ). In contrast, combined inhibition of NK 1 and NK 2 receptors does not result in the development of airway hyperresponsiveness after O 3 exposure (Table 2) . Neonatal Cap pretreatment also resulted in greater O 3 -induced neutrophil influx and protein extravasation (Table 4 ). In addition, rats treated neonatally with Cap had more pronounced decreases in V E during O 3 exposure than did control rats (Fig. 2) .
Sterner-Kock et al. (37) have previously reported that, in Wistar rats treated neonatally with Cap, 1 ppm O 3 exposure for 8 h caused more severe interstitial inflammation and epithelial necrosis, more protein in BAL fluid, and increased neutrophils in BAL fluid compared with Veh-treated rats. We also observed more neutrophils and more protein in BAL fluid in Captreated Sprague-Dawley rats (Table 4) exposed to 1 ppm O 3 for only 3 h. These observations with Captreated animals suggest that, in two different strains of rat, C fibers protect the lungs against O 3 -induced injury and consequent inflammation. The observation that, after O 3 exposure, treatment with TKRAs also increases the recovery of neutrophils in BAL fluid (Table  1) suggests that tachykinins mediate at least part of this protective effect provided by C fibers.
We had hypothesized that one way in which C fibers might be mediating these protective effects was through changes in V E. In particular, we reasoned that stimulation of C fibers by O 3 might lead to a decrease in V E in normal rats, which would not be present in the Captreated rats. The net effect would be that the Captreated rats received a greater dose of O 3 , resulting in greater inflammatory responses. Our results do not support this hypothesis. After a delay of ϳ70 min, V E did decrease to ϳ70% of values measured in the 20-min period immediately before O 3 exposure in Veh-treated rats (Fig. 2) , consistent with other reports (1, 25) . However, V E decreased earlier and to a greater extent in the Cap-treated rats (Fig. 2) . Tepper et al. (38) reported similar results in Cap-treated guinea pigs exposed to O 3 . Thus the increased inflammatory response to O 3 in Cap-treated rats (Table 4) is not the result of a greater inhaled dose of O 3 . In contrast, increased inflammation develops despite a lower inhaled dose.
The observations that V E and VT decreased to a greater extent in Cap-than in Veh-treated rats and that changes in the timing of the breath were not altered by Cap treatment indicate that C fibers are not the sensory arm of the changes in V E or ventilatory timing evoked by O 3 in rats. What is responsible for these changes? Other receptors, for example, rapidly adapting pulmonary stretch receptors and upper airway receptors, are also stimulated during O 3 exposure (1, 4) . In dogs, data obtained during CO 2 rebreathing after O 3 exposure suggest that slowly adapting pulmonary stretch receptors are sensitized by O 3 (31), although direct recordings from slowly adapting pulmonary stretch receptors do not indicate any consistent activation of these fibers by O 3 (4) . The effect of vagotomy or vagal cooling on ventilatory responses to Values are means Ϯ SE; n ϭ 8 animals for air-exposed and 6 animals for O 3 -exposed groups. Cells are expressed as no. of cells in bronchoalveolar lavage fluid ϫ 10 5 . *P Ͻ 0.02 by ANOVA; † P Ͻ 0.02 comparing O 3 -exposed, vehicle-treated group with air-exposed groups (vehicle and capsaicin combined, n ϭ 16); ‡ P Ͻ 0.02 comparing O 3 -exposed, capsaicin-treated group with air-exposed groups; § P Ͻ 0.02 comparing O 3 -exposed, capsaicin-treated group with O 3 -exposed, vehicle-treated group. Values are means Ϯ SE of data from 11 vehicle-and 11 capsaicin-treated rats. Minute ventilation (V E), tidal volume (VT), breathing frequency (f), inspiratory time (TI), and expiratory time (TE) were measured in each animal as the mean values over 20-min period immediately preceding O 3 (or air) exposure. O 3 in rats has not been evaluated, but in awake dogs O 3 exposure still results in decreases in VT and TI, even in dogs with both cervical vagi cooled to 0°C (31), suggesting that nonvagal mechanisms may be important. For example, it is possible that decreases in V E evoked by O 3 are the result of changes in metabolic rate. Both our laboratory and others have reported a decrease in O 2 consumption, core body temperature, and heart rate during O 3 exposure in rats (15, 25, 32) . Furthermore, the decrease in V E induced by O 3 occurs with only a very small change in arterial partial pressure of CO 2 (40) . V E declined fairly slowly after initiation of O 3 exposure (Fig. 2) . In addition, when the O 3 flow into the chamber was turned off, V E remained low for approximately another 25 min before gradually returning to preexposure levels (data not shown). This time course suggests that formation and release of certain chemical mediators may be necessary to evoke changes in V E. For example, O 3 exposure causes increased tumor necrosis factor-␣ (TNF-␣) expression in alveolar macrophages (28) . TNF-␣ is a cryogenic factor (21) and could contribute to the decreases in core body temperature and O 2 consumption observed.
It is not apparent why V E decreases more in the Cap-treated rats, but one possibility is that increased inflammation and injury, caused by loss of protective effects of tachykinins released from the peripheral ends of the neurons, result in increased generation of mediators such as TNF-␣. Our laboratory (15) has previously reported that the decreased core body temperature and heart rate that occur in response to O 3 are not different in Cap-and Veh-treated rats, suggesting that metabolic rate decreases to the same extent in both groups.
However, De Sanctis et al. (5) have reported a decreased ventilatory response to hypoxic gas mixtures in Cap-treated rats, probably resulting from loss of tachykinins in the neurons subtending the carotid bodies. It is possible that loss of responsiveness to hypoxia allows the Cap-treated animals to decrease V E to a greater extent than O 2 consumption. O 3 causes damage to the airway epithelium including vacuolation, sloughing, and necrosis (37) , and there is reason to believe that tachykinin effects on the airway epithelium could mediate the protective role of these peptides during O 3 exposure. Baluk et al. (2) reported that 85% of SP-immunoreactive sensory axons in the rat respiratory tract are located in close proximity to the epithelium, and Sertl et al. (34) showed that SP receptors were concentrated in the epithelium of the central airways in the rat lung. Tachykinins stimulate epithelial cell migration and proliferation (17) . Finally, in cultured bronchial epithelial cells, pretreatment with SP decreases permeability to mannitol, a marker of tight junction permeability. Furthermore, O 3 -induced increases in epithelial permeability were attenuated in cells treated with SP (48) . These data suggest that SP maintains epithelial cell integrity otherwise damaged by O 3 . Weakened epithelial integrity caused by O 3 in the absence of tachykinins could reflect enhanced O 3 -induced injury and result in the generation of increased neutrophil chemotactic factors.
Tachykinins also have effects on airway blood flow and mucous secretion that may protect the airways from O 3 -induced damage. In rat airways, injection of SP increases microvascular blood flow through NK 1 receptors (29) , and mucosal application of SP stimulates mucous secretion in an isolated trachea preparation (46) . Increased blood flow to airway mucosa could facilitate removal of O 3 from the airway surface, and increased mucous secretion could contribute to the protection by covering the epithelium and reducing the concentration of O 3 that actually reaches the lung surface.
Exposure to O 3 (1 ppm for 3 h) did not cause any change in airway responsiveness to inhaled aerosolized methacholine in Veh (control)-treated rats (Table 2) . These results are similar to reports by our laboratory and others of rats of the same strain exposed to the same concentrations of O 3 (15, 39) and measured at the same point in time after O 3 exposure, although airway hyperresponsiveness can be induced in rats with higher concentrations of O 3 or in other strains (9, 42) . However, our laboratory (15) has previously reported that, even though O 3 exposure did not induce an increase in airway responsiveness in Veh-treated rats, the same concentration and time of O 3 exposure did increase responsiveness in Cap-treated rats. In contrast, combined inhibition of NK 1 and NK 2 receptors throughout O 3 exposure and methacholine challenge did not result in airway hyperresponsiveness (Table 2 ). These results suggest that tachykinins per se are not involved in the development of O 3 -induced hyperresponsiveness in rats, even though C fibers are. It is unlikely that the lack of effect of the TKRAs on airway hyperresponsiveness reflects inadequate receptor antagonism. Treatment with CP-99994 and SR-48968 caused a log shift in the dose of SP required to elicit a change in blood pressure ( Table 3 ). The observation that TKRA treatment also altered the BAL cell profile (Table 1) further supports the efficacy of the receptor antagonists. One possible explanation for the augmentation of airway responsiveness by Cap pretreatment but not by tachykininreceptor inhibition is that substances other than tachykinins present in C fibers are important. Possible candidates are calcitonin gene-related peptide and nitric oxide (NO). Both are colocalized with tachykinins in C fibers and act as bronchodilators (3, 7, 11) . Absence of these potent bronchodilators coreleased from C-fiber endings on O 3 stimulation might be responsible for augmented airway responsiveness in Cap-pretreated rats.
There were also differences between TKRA treatment and neonatal Cap treatment in the effects on O 3 -induced BAL protein changes. BAL protein concentration was significantly increased in O 3 -exposed, Captreated rats compared with Veh-treated rats, but TKRAs did not alter the effects of O 3 on BAL protein, despite significant increases in BAL neutrophils (Table 1) .
These results suggest that substances other than tachykinins present in C fibers may act to counteract the O 3 -induced changes in vascular permeability that lead to changes in protein. NO has been reported to maintain pulmonary vascular endothelial integrity (11, 20) , and, in guinea pig airways, inhibition of endogenous NO resulted in enhancement of vagally induced plasma albumin leakage (20) . Lack of the endogenous NO present in C-fiber endings may thus contribute to the increased plasma protein leakage induced by O 3 exposure in Cap-treated animals.
There is evidence of species differences in the effect of C fibers on O 3 -induced airway responsiveness. In guinea pigs, depletion of neuropeptides by Cap treatment attenuates O 3 -induced airway hyperresponsiveness (38) . In rats, Cap pretreatment promotes airway hyperresponsiveness after O 3 exposure (15) . One potential explanation for this species difference is the differing bronchoconstrictor potency of tachykinins. In guinea pigs, SP and NKA are both potent bronchoconstrictors (19) , whereas, in rats, depending on the strain, the tachykinins either have a weak constrictor potential (16) or actually cause dilation (6) . In contrast, effects of Cap pretreatment on lung injury induced by O 3 appear to be similar in the two species. Both in this study in rats (Table 4 ) and in the study of Tepper et al. (38) in guinea pigs, increased protein in BAL fluid was observed in Cap-treated animals compared with Vehtreated controls. Similar results were obtained by Sterner-Kock et al. (37) . The accumulation of protein in BAL has been shown to be a sensitive indicator of O 3 -induced pulmonary damage (43) . Hence, our data and those of others support the hypothesis that C fibers act to attenuate O 3 -induced pulmonary damage, at least in these two species. Similarly, evidence for a role for C fibers in inhibiting the development of airway injury and/or inflammation has also been obtained with other inhaled irritants. More severe lung injury and/or inflammation in the airways has been observed in C-fiber-ablated rats after chronic sulfur dioxide (22, 23) or hydrogen sulfide (30) exposure, and in Cap-treated guinea pigs after acute acrolein inhalation (41) .
In summary, our results show that, in rats, more neutrophils are recovered by BAL when tachykininreceptor antagonists are administered throughout O 3 exposure. These results are consistent with observations reported herein and with other reports of greater inflammation after O 3 exposure in Cap-treated rats lacking C fibers, compared with Veh-treated controls (37) . The greater inflammatory response does not appear to be the result of a greater inhaled dose of O 3 , because V E was decreased in Cap-treated rats relative to Veh-treated controls during O 3 exposure. Together, the results support the hypothesis that tachykinins released from peripheral ending of C fibers mediate at least part of the protective effects of these afferents against O 3 -induced pulmonary inflammation.
